Valuation: Kenvue Inc.

Market Cap 37.11B 33.15B 30.45B 27.66B 51.94B 3,515B 53.24B 364B 146B 1,855B 139B 136B 5,881B P/E 2026 *
21.6x
P/E 2027 * 18.6x
Enterprise Value 43.94B 39.26B 36.06B 32.75B 61.5B 4,162B 63.05B 430B 173B 2,197B 165B 161B 6,963B EV / Sales 2026 *
2.81x
EV / Sales 2027 * 2.72x
Free-Float
-
Yield 2026 *
4.31%
Yield 2027 * 4.4%
1 day-1.28%
1 week-0.97%
1 month+12.27%
3 months+0.36%
6 months+10.79%
Current year+11.94%
1 week 19.2
Extreme 19.2
20
1 month 17.16
Extreme 17.165
20
Current year 16.56
Extreme 16.555
20.13
1 year 15.88
Extreme 15.88
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 14/07/2025
Director of Finance/CFO 48 12/05/2026
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 01/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 59 08/05/2023
Date Insider Type Main position Quantity % Market Cap. Importance
10/2/26 A Free

General Counsel

50,503 0.0026%
10/2/26 A Free

Chief Operating Officer

50,946 0.0027%
10/2/26 A Free

Chief Technology Officer

33,203 0.0017%

Financials

2026 *2027 *
Net sales 15.62B 13.95B 12.81B 11.64B 21.86B 1,479B 22.41B 153B 61.53B 781B 58.61B 57.36B 2,475B 16.01B 14.31B 13.14B 11.94B 22.41B 1,517B 22.98B 157B 63.11B 801B 60.11B 58.82B 2,538B
Net income 1.72B 1.54B 1.41B 1.28B 2.41B 163B 2.47B 16.87B 6.79B 86.12B 6.47B 6.33B 273B 2B 1.78B 1.64B 1.49B 2.79B 189B 2.86B 19.54B 7.86B 99.75B 7.49B 7.33B 316B
Net Debt 6.83B 6.1B 5.61B 5.09B 9.56B 647B 9.8B 66.91B 26.92B 342B 25.64B 25.09B 1,082B 6.51B 5.82B 5.35B 4.86B 9.12B 617B 9.35B 63.82B 25.67B 326B 24.45B 23.93B 1,032B
Projected Income Statement - Annual - Kenvue Inc.
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Sector
-
Date Price Change Volume
30/10/26 $19.31 -1.28% 66,596,317
29/10/26 $19.56 +1.19% 12,324,528
28/10/26 $19.33 -0.51% 10,645,933
27/10/26 $19.43 -0.36% 15,866,807
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Kenvue Inc.
  1. Stock Market
  2. Stocks
  3. KVUE Stock